cannabis indica

Disfunção Cognitiva

termo de indexação original: Cognitive Dysfunction

O acervo do Cannabis Indica reúne 414 estudos científicos que tocam a condição Disfunção Cognitiva, publicados entre 1998 e 2024. Pela leitura automatizada, 215 (52%) foram classificados como favoráveis, 86 (21%) como inconclusivos e 113 (27%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (148 estudos), seguido de estudo em animais (91). Os compostos mais presentes são Tetraidrocanabinol (THC), Endocanabinoide (não especificado) e Anandamida (AEA). Aparece com frequência ao lado de Efeitos Adversos da Cannabis, Ansiedade e Transtornos de Comportamento.

Estudos indexados
414
Período coberto
1998–2024
Favoráveis
215 · 52%
Inconclusivos
86 · 21%
Desfavoráveis
113 · 27%
Termo original
Cognitive Dysfunction

O acervo em números

Tipo de estudo

Metanálise148
Estudo em Animais91
Ensaio Clínico Duplo-Cego84
Ensaio Clínico63
Metanálise Clínica23
Estudo Laboratorial5

Direção do resultado

Favorável215
Inconclusivo86
Desfavorável113

Por década

1990s4
2000s22
2010s157
2020s231

414 estudos

Filtrar e buscar no acervo →

Esta página mostra 318 dos 414 estudos indexados sobre o tema, dos mais recentes aos mais antigos. Abra o acervo com este filtro para percorrer todos, ou baixe a lista completa em JSON e CSV.

  1. 2024

    A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDoenças Neurodegenerativas
  2. 2024

    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

    DesfavorávelMetanáliseAnsiedadeDepressãoPsicose+4
  3. 2024

    Cannabinoids as alleviating treatment for core symptoms of autism spectrum disorder in children and adolescents: a systematic review

    InconclusivoMetanálise ClínicaTranstornos de ComportamentoAutismo
  4. 2024

    Cognitive-behavioral therapies in the management of adolescents with cannabis use disorder (CUD): A systematic review

  5. 2024

    Evaluating possible 'next day' impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisInsônia e Distúrbios do Sono
  6. 2024

    Moving to Improve Mental Health - The Role of Exercise in Cognitive Function: A Narrative Review

  7. 2024

    Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDoenças NeurodegenerativasInsônia e Distúrbios do Sono+1
  8. 2024

    The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study

  9. 2024

    The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTiques e Síndrome de TouretteTHC:CBD Farmacêutico
  10. 2024

    The Impact of Cannabis Use on Cognition in People with HIV: Evidence of Function-Dependent Effects and Mechanisms from Clinical and Preclinical Studies

    InconclusivoMetanáliseInflamaçãoDoenças NeurodegenerativasHIV/AIDS
  11. 2024

    Understanding youth and young adult cannabis use in Canada post-legalization: a scoping review on a public health issue

    FavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+2
  12. 2023

    A - 93 The Impact of Motivation on Neuropsychological Performance in Chronic Cannabis Users

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  13. 2023

    A case of panic attack developing after THC-O acetate inhalation using an e-cigarette device

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+4
  14. 2023

    A systematic review of cannabidiol trials in neurodevelopmental disorders

    FavorávelMetanálise ClínicaDorInflamaçãoAnsiedadeAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+10
  15. 2023

    Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeTetraidrocanabinol (THC)
  16. 2023

    Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial

    DesfavorávelEnsaio Clínico
  17. 2023

    Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

  18. 2023

    Cannabidiol repairs behavioral and brain disturbances in a model of fetal alcohol spectrum disorder

    FavorávelEstudo em AnimaisAnsiedadeDepressãoEstresse OxidativoCanabicromeno (CBC)+4
  19. 2023

    Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

  20. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+15
  21. 2023

    Cannabis use does not increase actual creativity but biases evaluations of creativity

    InconclusivoEnsaio Clínico
  22. 2023

    Cannabis-Induced Acute Encephalopathy in a 94-Year-Old Woman Due to Family Administration of Cannabidiol (CBD) Products: A Case Report

  23. 2023

    CB1 receptor expression and signaling are required for dexamethasone-induced aversive memory consolidation

  24. 2023

    Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome

  25. 2023

    Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms

    DesfavorávelEnsaio Clínico Duplo-CegoDoenças NeurodegenerativasDoença de Parkinson
  26. 2023

    Could cannabinoids provide a new hope for ovarian cancer patients?

  27. 2023

    Delta-8-THC association with psychosis: A case report with literature review

  28. 2023

    Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study

  29. 2023

    Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder

  30. 2023

    Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability - a randomized clinical trial

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  31. 2023

    Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

    FavorávelMetanáliseCâncerInflamaçãoAnsiedadeCanabigerol (CBG)Canabinol (CBN)+20
  32. 2023

    Effects of Oral Cannabidiol on Health and Fitness in Healthy Adults: An 8-Week Randomized Trial

    FavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  33. 2023

    Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

  34. 2023

    Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice

    FavorávelEstudo em AnimaisInflamaçãoDoenças Neurodegenerativas
  35. 2023

    Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial

  36. 2023

    Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets

  37. 2023

    Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, Feasibility, Randomized-Controlled Trial

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisAnsiedadeAyahuasca
  38. 2023

    Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies

  39. 2023

    Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer's Disease

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasDoença de AlzheimerDemência
  40. 2023

    Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity

  41. 2023

    Prenatal THC exposure induces long-term, sex-dependent cognitive dysfunction associated with lipidomic and neuronal pathology in the prefrontal cortex-hippocampal network

  42. 2023

    Preventing Neurocognitive Decline in Adults Aging with HIV: Implications for Practice and Research

    FavorávelMetanáliseInflamaçãoDoenças NeurodegenerativasDoença de Alzheimer+3
  43. 2023

    Psychological Interventions for Cannabis Use among Adolescents and Young Adults: A Systematic Review

    FavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  44. 2023

    Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies

  45. 2023

    Structural organisation of perisomatic inhibition in the mouse medial prefrontal cortex

    InconclusivoEstudo em AnimaisDoenças NeurodegenerativasEndocanabinoide (não especificado)
  46. 2023

    Substance abuse and susceptibility to false memory formation: a systematic review and meta-analysis

  47. 2023

    Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

  48. 2023

    The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicoseTranstornos de Comportamento
  49. 2023

    The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review

    InconclusivoMetanáliseEfeitos Adversos da CannabisTHC:CBD Farmacêutico
  50. 2023

    The effects of cannabidiol on subjective states, cognition, and psychomotor function in healthy adults: A randomized clinical trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  51. 2023

    The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial

    FavorávelEnsaio ClínicoAnsiedadeTranstornos de Comportamento
  52. 2023

    The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology

  53. 2023

    The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  54. 2023

    Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain

    InconclusivoEnsaio Clínico Duplo-CegoDor — CrônicaDependência — OpioidesArtriteTHC Farmacêutico
  55. 2022

    [Effects of cannabis use on attention and memory in adolescent population: a systematic review]

  56. 2022

    A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication

  57. 2022

    A systematic review of the effects of cannabis on cognition in people with multiple sclerosis

    InconclusivoMetanáliseEsclerose Múltipla
  58. 2022

    Activation of CB1 pathway in the perirhinal cortex is necessary but not sufficient for destabilization of contextual fear memory in rats

    FavorávelEstudo em AnimaisEndocanabinoide (não especificado)
  59. 2022

    Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model

  60. 2022

    Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDepressãoPsicoseEsquizofreniaAnandamida (AEA)Palmitoiletanolamida (PEA)+3
  61. 2022

    Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC

  62. 2022

    An Ultra-Low Dose of ∆9-Tetrahydrocannabinol Alleviates Alzheimer's Disease-Related Cognitive Impairments and Modulates TrkB Receptor Expression in a 5XFAD Mouse Model

    FavorávelEstudo em AnimaisDoença de Alzheimer
  63. 2022

    Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects

  64. 2022

    Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis

  65. 2022

    Brain morphology predictors of alcohol, tobacco, and cannabis use in adolescence: A systematic review

  66. 2022

    Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice

    FavorávelEstudo em AnimaisAnsiedadeDoenças NeurodegenerativasDoença de Alzheimer
  67. 2022

    Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cocaína
  68. 2022

    Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study

  69. 2022

    Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion

    FavorávelEstudo em AnimaisDoença de AlzheimerMenopausa
  70. 2022

    Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

  71. 2022

    Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report

    FavorávelMetanáliseInflamaçãoAnsiedadeDepressão+4
  72. 2022

    Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

  73. 2022

    Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis

  74. 2022

    Cannabis for Medical Use: Versatile Plant Rather Than a Single Drug

  75. 2022

    Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms

    DesfavorávelMetanáliseDorDependência — CannabisAnsiedade+3
  76. 2022

    Cannabis-Based Products for Chronic Pain : A Systematic Review

  77. 2022

    Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study

  78. 2022

    Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial

    FavorávelEnsaio ClínicoAnsiedadeInsônia e Distúrbios do SonoQualidade de Vida
  79. 2022

    Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

  80. 2022

    Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

    FavorávelMetanáliseDorCâncerAnsiedadeTetraidrocanabinol (THC)THC Farmacêutico+17
  81. 2022

    Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

  82. 2022

    Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior

    FavorávelEnsaio Clínico Duplo-CegoPsicoseTranstornos de Comportamento
  83. 2022

    Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

  84. 2022

    Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review

    InconclusivoMetanáliseAnsiedadeDepressãoPsicose+4
  85. 2022

    Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study

    FavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDepressão
  86. 2022

    Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeEpilepsiaTetraidrocanabinol (THC)+1
  87. 2022

    Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis

    FavorávelMetanálise ClínicaEsclerose MúltiplaTHC:CBD Farmacêutico
  88. 2022

    Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving

  89. 2022

    Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

  90. 2022

    Endocannabinoid system contributions to sex-specific adolescent neurodevelopment

  91. 2022

    Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  92. 2022

    Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap

  93. 2022

    Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study

    FavorávelEnsaio ClínicoDoença de ParkinsonTetraidrocanabinol (THC)THC Farmacêutico
  94. 2022

    Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice

  95. 2022

    Harm Reduction Strategies among University Students Who Use Alcohol and Cannabis, and Related Psychological Variables: A Systematic Review

  96. 2022

    Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTHC Farmacêutico
  97. 2022

    Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis

  98. 2022

    Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

  99. 2022

    Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes

    DesfavorávelMetanáliseDorDependência QuímicaCâncerTHC:CBD Farmacêutico+14
  100. 2022

    Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review

  101. 2022

    Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFκBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats

  102. 2022

    Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

    FavorávelMetanáliseInflamaçãoDepressãoEstresse Oxidativo+4
  103. 2022

    Long-term Cannabis Users Show Lower Cognitive Reserves and Smaller Hippocampal Volume in Midlife

  104. 2022

    Long-term effects of prenatal cannabis exposure: Pathways to adolescent and adult outcomes

    DesfavorávelMetanálisePsicoseDependência — OpioidesDependência — Álcool+5
  105. 2022

    Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

  106. 2022

    LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAyahuasca+6
  107. 2022

    Mechanistic Insights into Ameliorating Effect of Geraniol on D-Galactose Induced Memory Impairment in Rats

    FavorávelEstudo em Animais
  108. 2022

    Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

  109. 2022

    Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP Swe /PS1ΔE9 Transgenic Female Mice

    FavorávelEstudo em AnimaisInflamaçãoAnsiedadeEstresse Oxidativo+4
  110. 2022

    Neuroprotective effect of alpha-pinene is mediated by suppression of the TNF-α/NF-κB pathway in Alzheimer's disease rat model

    FavorávelEstudo em AnimaisInflamaçãoAnsiedadeEstresse OxidativoMedicina Mente-Corpo+4
  111. 2022

    Pharmacological Activation of GPR55 Improved Cognitive Impairment Induced by Lipopolysaccharide in Mice

  112. 2022

    Phytol loaded PLGA nanoparticles ameliorate scopolamine-induced cognitive dysfunction by attenuating cholinesterase activity, oxidative stress and apoptosis in Wistar rat

    FavorávelEstudo em AnimaisDoença de Alzheimer
  113. 2022

    Prefrontal cortical distribution of muscarinic M2 and cannabinoid-1 (CB1) receptors in adult male mice with or without chronic adolescent exposure to Δ9-tetrahydrocannabinol

  114. 2022

    Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents

    DesfavorávelEnsaio ClínicoGestaçãoTranstornos de ComportamentoAlterações Cerebrais Neonatais+1
  115. 2022

    Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes

  116. 2022

    Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment

  117. 2022

    Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeTranstornos de Comportamento
  118. 2022

    Shifting the Paradigm on Cannabis Safety

    DesfavorávelMetanáliseCâncerInflamaçãoEfeitos Adversos da CannabisCBD Farmacêutico+16
  119. 2022

    Substance-induced psychosis and cognitive functioning: A systematic review

    DesfavorávelMetanáliseDependência QuímicaPsicoseEsquizofrenia
  120. 2022

    Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report

  121. 2022

    The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study

  122. 2022

    The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeTranstornos de ComportamentoTEPT
  123. 2022

    The effect of medical cannabis on cognitive functions: a systematic review

    DesfavorávelMetanálise ClínicaDorCâncerEfeitos Adversos da CannabisTHC:CBD FarmacêuticoCBD Farmacêutico+11
  124. 2022

    The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study

    DesfavorávelEnsaio Clínico Duplo-CegoAnsiedadePsicoseEsquizofreniaTetraidrocanabinol (THC)Endocanabinoide (não especificado)+4
  125. 2022

    The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta-analysis

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  126. 2022

    The Impact of Cannabis Decriminalization and Legalization on Road Safety Outcomes: A Systematic Review

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  127. 2022

    The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

  128. 2022

    Therapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidence

    FavorávelMetanálise ClínicaDorInflamaçãoEstresse OxidativoPalmitoiletanolamida (PEA)+8
  129. 2022

    Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association

    DesfavorávelMetanáliseAVC
  130. 2022

    Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome MetabólicaMicrobioma+1
  131. 2021

    "Light cannabis" consumption in a sample of young adults: Preliminary pharmacokinetic data and psychomotor impairment evaluation

    FavorávelEnsaio Clínico
  132. 2021

    A Mini-Review of Relationships Between Cannabis Use and Neural Foundations of Reward Processing, Inhibitory Control and Working Memory

  133. 2021

    A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability

    FavorávelEnsaio Clínico Duplo-CegoAutismoTDA e TDAH
  134. 2021

    A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis

    FavorávelMetanáliseInflamaçãoAnsiedadeDepressão+5
  135. 2021

    A standardized black pepper seed extract containing β-caryophyllene improves cognitive function in scopolamine-induced amnesia model mice via regulation of brain-derived neurotrophic factor and MAPK proteins

    FavorávelEstudo em Animais
  136. 2021

    Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ 1-42 through inhibiting RhoA/ROCK2 pathway

  137. 2021

    Acute effects of partial CB 1 receptor agonists on cognition - A meta-analysis of human studies

    DesfavorávelMetanálise ClínicaTHC Farmacêutico
  138. 2021

    Associations between adolescent cannabis use and young-adult functioning in three longitudinal twin studies

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  139. 2021

    Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoAyahuasca
  140. 2021

    Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction

    FavorávelEstudo em AnimaisInflamação
  141. 2021

    Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease

    FavorávelEstudo em AnimaisDoença de AlzheimerDemência
  142. 2021

    Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment

    InconclusivoMetanáliseDependência QuímicaAnsiedadeDepressão+10
  143. 2021

    Cannabidiol attenuates cognitive deficits and neuroinflammation induced by early alcohol exposure in a mice model

    FavorávelEstudo em AnimaisDependência QuímicaInflamaçãoDependência — Álcool+2
  144. 2021

    Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice

    FavorávelEstudo em AnimaisPsicoseEsquizofrenia
  145. 2021

    Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity

    FavorávelEstudo em AnimaisAVC
  146. 2021

    Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  147. 2021

    Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory

    FavorávelEstudo em AnimaisAnsiedadeAutismo
  148. 2021

    Cannabidiol for Mood Disorders: A Call for More Research

    DesfavorávelMetanáliseDorDor — CrônicaDepressão+3
  149. 2021

    Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration

    FavorávelMetanáliseDoenças NeurodegenerativasTranstornos de Comportamento
  150. 2021

    Cannabinoid control of hippocampal functions: the where matters

  151. 2021

    Cannabinoids for the treatment of dementia

  152. 2021

    Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  153. 2021

    Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — CrônicaTHC Farmacêutico+4
  154. 2021

    Cannabis Use in Pregnancy: A State of the Science Review

    DesfavorávelMetanáliseEfeitos Adversos da CannabisGestaçãoTranstornos de Comportamento+1
  155. 2021

    Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome

    FavorávelEstudo em AnimaisDorAnsiedadeDor — CrônicaÁcido Canabidiólico (CBD-a)+4
  156. 2021

    Cognition and Cortical Thickness in Heavy Cannabis Users

    DesfavorávelEnsaio ClínicoEfeitos Adversos da CannabisDependência — Cannabis
  157. 2021

    Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults

    InconclusivoEnsaio ClínicoDependência — ÁlcoolTDA e TDAH
  158. 2021

    Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review

    DesfavorávelMetanálise Clínica
  159. 2021

    Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice

    InconclusivoEstudo em AnimaisAnsiedadeGestaçãoAlterações Cerebrais NeonataisCBD Farmacêutico
  160. 2021

    Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments

    FavorávelEstudo em AnimaisAnsiedadeAVC
  161. 2021

    Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review

    FavorávelMetanálise ClínicaDorEfeitos Adversos da Cannabis
  162. 2021

    Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  163. 2021

    Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters

    InconclusivoEnsaio Clínico Duplo-CegoAnsiedade
  164. 2021

    Effects of repeated adolescent exposure to cannabis smoke on cognitive outcomes in adulthood

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisAnsiedadeCanabinol (CBN)
  165. 2021

    Effects of vapourized THC and voluntary alcohol drinking during adolescence on cognition, reward, and anxiety-like behaviours in rats

    InconclusivoEstudo em AnimaisDependência QuímicaAnsiedadeDependência — Álcool
  166. 2021

    Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice

    DesfavorávelEstudo em AnimaisTHC:CBD Farmacêutico
  167. 2021

    Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research

    FavorávelMetanáliseDorDependência QuímicaCâncer+16
  168. 2021

    Impact of Acute and Chronic Cannabis Use on Stress Response Regulation: Challenging the Belief That Cannabis Is an Effective Method for Coping

  169. 2021

    Intelligence quotient decline following frequent or dependent cannabis use in youth: a systematic review and meta-analysis of longitudinal studies

  170. 2021

    Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder

  171. 2021

    Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review

  172. 2021

    Potential Role of Cannabidiol on Sports Recovery: A Narrative Review

    FavorávelMetanáliseDorAnsiedadeEstresse Oxidativo+2
  173. 2021

    Potential therapeutic uses of cannabinoids to treat behavioural problems in children and adolescents with developmental disorders

    FavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+8
  174. 2021

    PPARγ receptors are involved in the effects of cannabidiol on orofacial dyskinesia and cognitive dysfunction induced by typical antipsychotic in mice

    FavorávelEstudo em AnimaisInflamaçãoPsicoseDoenças Neurodegenerativas
  175. 2021

    Prenatal cannabis use disorders and offspring primary and secondary educational outcomes

  176. 2021

    Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement

    DesfavorávelMetanáliseAnsiedadePsicoseEsquizofrenia+1
  177. 2021

    Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

  178. 2021

    Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

  179. 2021

    Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicoseEsquizofrenia+1
  180. 2021

    Structural correlates of sensorimotor dysfunction in heavy cannabis users

  181. 2021

    Systematic review and meta-analysis of socio-cognitive and socio-affective processes association with adolescent substance use.

  182. 2021

    THC Exposure is Reflected in the Microstructure of the Cerebral Cortex and Amygdala of Young Adults

    InconclusivoEnsaio ClínicoDPOC
  183. 2021

    The Alerting and Orienting Systems of Attention Are Modified by Cannabis Dependence

  184. 2021

    The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice

    InconclusivoEstudo em AnimaisAnsiedadeTEPTCanabigerol (CBG)
  185. 2021

    The endocannabinoid system in the amygdala and modulation of fear

  186. 2021

    The Impact of THC and CBD in Schizophrenia: A Systematic Review

    InconclusivoMetanáliseDependência QuímicaDependência — CannabisPsicose+1
  187. 2021

    The Neuroprotective properties, Functions and Roles of Cannabis sativa in selected diseases related to the Nervous System

  188. 2021

    The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review

  189. 2021

    The Role of Cannabidiol in Neurological Disorders

  190. 2021

    Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease

  191. 2021

    Using Mendelian randomization analysis to better understand the relationship between mental health and substance use: a systematic review

  192. 2021

    Young and under the influence: A systematic literature review of the impact of cannabis on the driving performance of youth

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  193. 2021

    β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19

    InconclusivoMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)AVC+7
  194. 2020

    A review investigating the relationship between cannabis use and adolescent cognitive functioning

    DesfavorávelMetanálise
  195. 2020

    A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadePsicoseEsquizofreniaAnandamida (AEA)
  196. 2020

    Acute and residual mood and cognitive performance of young adults following smoked cannabis

    InconclusivoEnsaio Clínico Duplo-Cego
  197. 2020

    Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisTranstornos de Comportamento
  198. 2020

    Attenuation of Oxidative Stress by Cannabinoids and Cannabis Extracts in Differentiated Neuronal Cells

  199. 2020

    Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research

    FavorávelMetanáliseDorInflamaçãoAnsiedade+6
  200. 2020

    Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis

    FavorávelMetanáliseDemência
  201. 2020

    Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship

    DesfavorávelMetanáliseCanabinoide Sintético (não especificado)
  202. 2020

    Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease

    DesfavorávelMetanáliseEfeitos Adversos da CannabisEsquizofreniaGestação+4
  203. 2020

    Cannabis Exposure Is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV

    FavorávelMetanáliseHIV/AIDS
  204. 2020

    Cannabis increases susceptibility to false memory

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  205. 2020

    Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence

    InconclusivoMetanálise
  206. 2020

    CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim

    FavorávelEstudo em AnimaisDepressãoTranstornos de ComportamentoTEPT
  207. 2020

    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice

    FavorávelEstudo em AnimaisInflamaçãoDoenças NeurodegenerativasTranstornos de Comportamento+1
  208. 2020

    Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy

    FavorávelEnsaio ClínicoEpilepsiaTranstornos de ComportamentoCBD Farmacêutico
  209. 2020

    Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences

    DesfavorávelMetanálise
  210. 2020

    Downregulation of the CB1-Mediated Endocannabinoid Signaling Underlies D-Galactose-Induced Memory Impairment

    InconclusivoEstudo em Animais
  211. 2020

    Effectiveness of Cannabinoids for Treatment of Dementia: A Systematic Review of Randomized Controlled Trials

    FavorávelMetanálise ClínicaDoença de AlzheimerTHC Farmacêutico
  212. 2020

    Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers

    InconclusivoEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaTHC Farmacêutico
  213. 2020

    Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer's Disease

    FavorávelMetanáliseDorInflamaçãoEstresse Oxidativo+2
  214. 2020

    Endocannabinoid genetic variation enhances vulnerability to THC reward in adolescent female mice

  215. 2020

    Endocannabinoid Signaling for GABAergic-Microglia (Mis)Communication in the Brain Aging

  216. 2020

    Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity

  217. 2020

    Inner Engineering Practices and Advanced 4-day Isha Yoga Retreat Are Associated with Cannabimimetic Effects with Increased Endocannabinoids and Short-Term and Sustained Improvement in Mental Health: A Prospective Observational Study of Meditators

  218. 2020

    Investigating the causal effect of cannabis use on cognitive function with a quasi-experimental co-twin design

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  219. 2020

    Medical cannabis and cognitive performance in middle to old adults treated for chronic pain

    FavorávelMetanáliseDorDor — Crônica
  220. 2020

    Mobile Assessment of Acute Effects of Marijuana on Cognitive Functioning in Young Adults: Observational Study

    DesfavorávelMetanálise
  221. 2020

    Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis

    DesfavorávelMetanálise ClínicaAnsiedadeDepressãoPsicose
  222. 2020

    Safety and Efficacy of Cannabis in Autism Spectrum Disorder

    FavorávelMetanáliseAnsiedadeDepressãoAutismo+1
  223. 2020

    Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults

    InconclusivoEnsaio ClínicoEfeitos Adversos da Cannabis
  224. 2020

    Synthetic Cannabinoids and Its Association With Persistent Negative Symptoms of Schizophrenia

  225. 2020

    Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer's Disease Lymphoblast Alterations

  226. 2020

    The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  227. 2020

    The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling

  228. 2020

    The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study

  229. 2020

    Therapeutic potential of ayahuasca in grief: a prospective, observational study

    FavorávelEnsaio ClínicoAnsiedadeDepressãoPsicoseAyahuasca+1
  230. 2020

    Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children

    InconclusivoEnsaio ClínicoInflamaçãoProteína Ligadora de Ácidos Graxos (FABP)
  231. 2020

    Δ 9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTHC Farmacêutico
  232. 2019

    24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone

  233. 2019

    A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC

  234. 2019

    Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  235. 2019

    Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisEsquizofrenia
  236. 2019

    Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans

  237. 2019

    Adolescent cannabis use and its associations with decision-making and episodic memory: Preliminary results from a longitudinal study

    DesfavorávelMetanálise
  238. 2019

    Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood

    DesfavorávelEstudo em Animais
  239. 2019

    Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis

    InconclusivoMetanálisePsicoseDoenças NeurodegenerativasEsquizofrenia
  240. 2019

    Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.

    FavorávelMetanáliseDiabetes
  241. 2019

    Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

    DesfavorávelEnsaio Clínico Duplo-CegoPsicoseTetraidrocanabinol (THC)
  242. 2019

    Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series

    FavorávelMetanáliseAnsiedadeDepressãoInsônia e Distúrbios do Sono+3
  243. 2019

    Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasSíndrome de RettCanabidivarina (CBDV)
  244. 2019

    Cannabinoid toxicity in pediatrics

  245. 2019

    Cannabis-induced altered states of consciousness are associated with specific dynamic brain connectivity states

    InconclusivoEnsaio ClínicoPsicoseTranstornos de Comportamento
  246. 2019

    Cerebellar alterations in cannabis users: A systematic review

    DesfavorávelMetanálise ClínicaDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+2
  247. 2019

    Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study

  248. 2019

    Co-ultraPEALut: Role in Preclinical and Clinical Delirium Manifestations

    FavorávelEnsaio ClínicoInflamaçãoEstresse OxidativoPalmitoiletanolamida (PEA)
  249. 2019

    Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis

    DesfavorávelEnsaio ClínicoEsclerose Múltipla
  250. 2019

    Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: A comprehensive review of randomized-controlled studies

    FavorávelMetanálise ClínicaDorDependência — CannabisDor — Crônica
  251. 2019

    Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication

  252. 2019

    Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial

  253. 2019

    Effect of Smoked Cannabis on Vigilance and Accident Risk Using Simulated Driving in Occasional and Chronic Users and the Pharmacokinetic-Pharmacodynamic Relationship

    DesfavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  254. 2019

    Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats

    FavorávelEstudo em AnimaisDiabetes
  255. 2019

    Enhancing effects of acute exposure to cannabis smoke on working memory performance

    FavorávelEstudo em AnimaisTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  256. 2019

    Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisPsicoseTetraidrocanabinol (THC)
  257. 2019

    Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans

  258. 2019

    Joint effects of stress and chronic cannabis use on prospective memory

    InconclusivoMetanáliseEfeitos Adversos da CannabisEstresse Oxidativo
  259. 2019

    Longitudinal Alterations in Prefrontal Resting Brain Connectivity in Non-Treatment-Seeking Young Adults With Cannabis Use Disorder

    DesfavorávelMetanáliseEfeitos Adversos da Cannabis
  260. 2019

    Medical Cannabis for the Treatment of Dementia: A Review of Clinical Effectiveness and Guidelines

    FavorávelMetanáliseDemênciaCondições GeriátricasTHC Farmacêutico
  261. 2019

    Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

    FavorávelMetanáliseDemência
  262. 2019

    Positive and Negative Effects of Cannabis and Cannabinoids on Health

    InconclusivoMetanáliseEfeitos Adversos da CannabisEsquizofrenia
  263. 2019

    Prescription of a THC/CBD-Based Medication to Patients with Dementia: A Pilot Study in Geneva

    FavorávelEnsaio ClínicoDoenças NeurodegenerativasDoença de AlzheimerDemência
  264. 2019

    Regional Changes in the Type 1 Cannabinoid Receptor Are Associated With Cognitive Dysfunction in Parkinson's Disease

    InconclusivoMetanáliseDoença de Parkinson
  265. 2019

    Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition

    FavorávelMetanáliseEsquizofrenia
  266. 2019

    Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasDoença de AlzheimerDemência
  267. 2019

    Synergistic effects of marijuana abuse and HIV infection on neural activation during a cognitive interference task

    DesfavorávelMetanáliseEfeitos Adversos da CannabisHIV/AIDS
  268. 2019

    The Acute and Chronic Cognitive and Cerebral Blood-Flow Effects of Nepalese Pepper ( Zanthoxylum armatum DC.) Extract-A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Humans

    FavorávelEnsaio Clínico Duplo-CegoEndocanabinoide (não especificado)
  269. 2019

    The cannabinoid receptor 2 agonist, β-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice

    FavorávelEstudo em AnimaisInflamação
  270. 2019

    The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species

  271. 2019

    The Endocannabinoid System as a Potential Mechanism through which Exercise Influences Episodic Memory Function

    FavorávelMetanáliseExercício Físico
  272. 2019

    Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture

    FavorávelEstudo em AnimaisEstresse OxidativoSepse
  273. 2019

    Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors

    InconclusivoEstudo em AnimaisAnsiedadeDepressãoTranstornos de Comportamento+1
  274. 2018

    A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders

  275. 2018

    Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

  276. 2018

    Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  277. 2018

    Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex

    DesfavorávelEstudo em AnimaisEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  278. 2018

    Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload.

    FavorávelEstudo em Animais
  279. 2018

    Approach bias modification for cannabis use disorder: A proof-of-principle study

    FavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  280. 2018

    Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  281. 2018

    Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis

  282. 2018

    Biphasic effects of THC in memory and cognition.

  283. 2018

    Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans

    DesfavorávelEnsaio Clínico Duplo-CegoCanabinoides Sintéticos AM-xCanabinoides Sintéticos CP-x
  284. 2018

    Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoEstresse Oxidativo
  285. 2018

    Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats

    FavorávelEstudo em AnimaisTetraidrocanabinol (THC)
  286. 2018

    Early Cannabis Use and Neurocognitive Risk: A Prospective Functional Neuroimaging Study

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  287. 2018

    Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadePsicoseEsquizofreniaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  288. 2018

    Effects of acute Δ9-tetrahydrocannabinol on next-day extinction recall is mediated by post-extinction resting-state brain dynamics

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  289. 2018

    Epidemiological Characteristics, Safety And Efficacy Of Medical Cannabis In The Elderly

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides+2
  290. 2018

    Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder

  291. 2018

    Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice

  292. 2018

    Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses

  293. 2018

    Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function.

    DesfavorávelEnsaio Clínico Duplo-CegoPsicoseTetraidrocanabinol (THC)
  294. 2018

    Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

  295. 2018

    Linalool bioactive properties and potential applicability in drug delivery systems

    FavorávelMetanáliseDorCâncerInflamaçãoMedicina Mente-Corpo+9
  296. 2018

    Marijuana Matters: Reviewing the Impact of Marijuana on Cognition, Brain Structure and Function, & Exploring Policy Implications and Barriers to Research

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  297. 2018

    Memory impairment in HIV-infected individuals with early and late initiation of regular marijuana use

    DesfavorávelMetanáliseEfeitos Adversos da CannabisHIV/AIDS
  298. 2018

    Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicoseTetraidrocanabinol (THC)
  299. 2018

    Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study

  300. 2018

    One Month of Cannabis Abstinence in Adolescents and Young Adults Is Associated With Improved Memory

  301. 2018

    Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities

    FavorávelMetanáliseDepressãoEpilepsia
  302. 2017

    Cognitive motor deficits in cannabis users

    InconclusivoMetanálise
  303. 2017

    Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  304. 2016

    Cannabis-induced Moto-Cognitive Dysfunction in Wistar Rats: Ameliorative Efficacy of Nigella Sativa

    FavorávelEstudo em Animais
  305. 2016

    Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates

    FavorávelEstudo em AnimaisAnandamida (AEA)Tetraidrocanabinol (THC)
  306. 2015

    Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  307. 2015

    Dose-dependent effects of cannabis on the neural correlates of error monitoring in frequent cannabis users

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaCâncerEfeitos Adversos da CannabisTetraidrocanabinol (THC)+1
  308. 2015

    Marijuana's acute effects on cognitive bias for affective and marijuana cues

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  309. 2015

    Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da Cannabis
  310. 2014

    Effects of 20 mg oral Δ(9) -tetrahydrocannabinol on the olfactory function of healthy volunteers

  311. 2012

    Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression

    DesfavorávelEnsaio ClínicoDepressãoAnandamida (AEA)Endocanabinoide (não especificado)+1
  312. 2010

    Modulation of risk-taking in marijuana users by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex (DLPFC)

    DesfavorávelEnsaio ClínicoEfeitos Adversos da Cannabis
  313. 2009

    Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis

    InconclusivoEnsaio Clínico
  314. 2009

    Neuroimaging in cannabis use: a systematic review of the literature

    FavorávelMetanálise ClínicaTetraidrocanabinol (THC)
  315. 2008

    Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

    DesfavorávelEnsaio Clínico Duplo-Cego
  316. 2005

    Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats

    FavorávelEstudo em AnimaisEfeitos Adversos da Cannabis
  317. 1999

    Effect of cannabis use on cognitive functions and driving ability

    DesfavorávelEnsaio Clínico
  318. 1998

    Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana

    InconclusivoEnsaio Clínico

Continue por aqui

Perguntas frequentes

Quantos estudos sobre disfunção cognitiva estão indexados no acervo?
São 414 estudos, publicados entre 1998 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 148 · Estudo em Animais: 91 · Ensaio Clínico Duplo-Cego: 84 · Ensaio Clínico: 63 · Metanálise Clínica: 23 · Estudo Laboratorial: 5. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 215 favoráveis, 86 inconclusivos e 113 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Disfunção Cognitiva — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/disfuncao-cognitiva/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Disfunção Cognitiva — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/disfuncao-cognitiva/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.